Literature DB >> 9204477

Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies.

R Naef1, K Adlkofer, B Lescher, U Suter.   

Abstract

The naturally occurring mouse mutant Trembler (Tr) represents an animal model for inherited human neuropathies caused by point mutations affecting peripheral myelin protein 22 (PMP22). We describe the likely pathogenic cellular mechanism underlying the observed myelin deficiency. In Tr/+ animals, PMP22 immunoreactivity was found not only in compact myelin but also abundantly in the cytoplasm of Schwann cells. Based on these observations, the biosynthesis of wildtype and Tr protein was examined in transfected cells. While wildtype PMP22 was readily transported to the plasma membrane, Tr protein was localized mainly in the endoplasmic reticulum. Coexpression revealed a dominant effect of Tr on protein trafficking of wildtype PMP22. In agreement with the findings in vitro, Tr protein was not detectable in myelin of Tr/0 mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204477     DOI: 10.1006/mcne.1997.0604

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  25 in total

Review 1.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  Neurons promote the translocation of peripheral myelin protein 22 into myelin.

Authors:  S Pareek; L Notterpek; G J Snipes; R Naef; W Sossin; J Laliberté; S Iacampo; U Suter; E M Shooter; R A Murphy
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22.

Authors:  Andreas R Tobler; Ning Liu; Lukas Mueller; Eric M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.

Authors:  Mehrdad Khajavi; Ken Inoue; Wojciech Wiszniewski; Tomoko Ohyama; G Jackson Snipes; James R Lupski
Journal:  Am J Hum Genet       Date:  2005-09-30       Impact factor: 11.025

Review 5.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 6.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy.

Authors:  L Notterpek; E M Shooter; G J Snipes
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

Review 8.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

9.  A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes.

Authors:  Kleopas A Kleopa; Domna-Maria Georgiou; Paschalis Nicolaou; Pantelitsa Koutsou; Eleftherios Papathanasiou; Theodoros Kyriakides; Kyproula Christodoulou
Journal:  Neurogenetics       Date:  2004-06-17       Impact factor: 2.660

10.  Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases.

Authors:  K M Dickson; J J M Bergeron; I Shames; J Colby; D T Nguyen; E Chevet; D Y Thomas; G J Snipes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.